机译:KL-6是评估乳腺癌和膀胱癌而非结肠癌微乳头型的另一种有用标记
Division of Pathology, Matsuyama-shimin Hospital, Matsuyama, Ehime 790-0067, Japan;
Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan;
Department of Surgery, Matsuyama-shimin Hospital, Matsuyama,Ehime, Japan;
Department of Surgery, Matsuyama-shimin Hospital, Matsuyama,Ehime, Japan;
Department of Urology, Matsuyama-shimin Hospital, Matsuyama, Ehime, Japan;
Division of Pathology, Matsuyama-shimin Hospital, Matsuyama, Ehime 790-0067, Japan;
Department of Pathology, Kochi Medical School, Kochi University, Kochi, Japan;
Department of Pathology, Kochi Medical School, Kochi University, Kochi, Japan;
KL-6; EMA; MUC1; CD10; micropapillary carcinoma; immunohistochemistry;
机译:KL-6是评估乳腺癌和膀胱癌而非结肠癌微乳头型的另一种有用标记
机译:转移至膀胱和子宫内膜的乳腺浸润性微乳头状癌:诊断缺陷和具有微乳头状特征的肿瘤文献综述。
机译:浸润性微乳头状癌与微乳头成分癌与乳腺浸润性导管癌之间的预后因素和失败模式的差异:回顾性多中心病例对照研究(KROG 13-06)
机译:乳腺浸润性微乳头状癌中CD146的表达增加和微血管密度(MVD):与浸润性导管癌的比较研究(未另作说明)
机译:膀胱尿路上皮癌的免疫学方面:T细胞共刺激和共抑制作用。
机译:乳腺纯黏液性癌中微乳头型的预后意义:与微乳头状癌的比较分析
机译:乳头状粘液性微乳头型的预后意义:微乳头癌的对比分析